Kloster-Jensen, Kristine <br/><br/>
Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids.  [electronic resource] 

 -  Journal of diabetes research  2016 
 - 4196460 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2314-6753 
<br/><br/><label>Standard No.: </label>10.1155/2016/4196460  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Apoptosis<br/>Body Mass Index<br/>Cells, Cultured<br/>Cytokines--metabolism<br/>Drug Synergism<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Glucose--chemistry<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Inflammation<br/>Insulin--metabolism<br/>Insulin Secretion<br/>Islets of Langerhans--drug effects<br/>Islets of Langerhans Transplantation<br/>Male<br/>Methylprednisolone--chemistry<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>RNA, Messenger--metabolism<br/>Sirolimus--administration & dosage<br/>Tacrolimus--administration & dosage